Zh. Yan et al., REGULATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INDUCED TRANSACTIVATION BY THE NUCLEAR ORPHAN RECEPTOR TAK1 TR4/, The Journal of biological chemistry, 273(18), 1998, pp. 10948-10957
Recently, Re reported the cloning of the nuclear orphan receptor TAK1.
In this study, we characterized the sequence requirements for optimal
TAK1 binding and analyzed the repression of the peroxisome proliferat
or-activated receptor alpha (PPAR alpha) signaling pathway by TAK1. Si
te selection analysis showed that TAK1 has the greatest affinity for d
irect repeat-1 response elements (RE) containing AGGTCAAAGGTCA (TAK1-R
E) to which it binds as a homodimer, TAK1 is a very weak inducer of TA
K1-RE-dependent transcriptional activation. We observed that TAK1, as
PPAR alpha; is expressed within rat hepatocytes and is able to bind th
e peroxisome proliferator response elements (PPREs) present in the pro
moter of the PPAR alpha target genes rat enoyl-CoA hydratase (HD) and
peroxisomal fatty acyl-CoA oxidase (ACOX). TAK1 is unable to induce PP
RE-dependent transcriptional activation and represses PPAR alpha-media
ted transactivation through these elements in a dose-dependent manner.
Two-hybrid analysis showed that TAK1 does not form heterodimers with
either PPAR alpha or retinoid X receptor (RXR alpha), indicating that
this repression does not involve a mechanism by which TAK1 titrates ou
t PPAR alpha or RXR alpha from PPAR.RXR complexes. Further studies dem
onstrated that the PPAR alpha Ligand 8(S)-hydroxyeicosatetraenoic acid
strongly promotes the interaction of PPAR alpha with the co-activator
RIP-140 but decreases the interaction of PPAR alpha with the corepres
sor SMRT. In contrast, TAK1 interacts with RIP-140 but not with SMRT a
nd competes with PPAR alpha for RIP-140 binding. These observations in
dicated that the antagonistic effects of TAK1 on PPAR alpha.RXR alpha
transactivation act at least at two levels in the PPAR alpha signaling
pathway: competition of TAK1 with PPAR alpha.RXR for binding to PPREs
as well as to common co-activators, such as RIP-140. Our results sugg
est an important role for TAK1 in modulating PPAR alpha-controlled gen
e expression in hepatocytes.